Vitaccess announces first-of-its-kind CIDP Registry and first patient enrolled in landmark patient-centered evidence platform
Boston, MA, USA and London, UK – 8 April 2026, Vitaccess, a leader in generating science-driven real-world evidence, announces the launch of the Vitaccess Real CIDP Registry, a first-of-its-kind patient-centered registry in chronic inflammatory demyelinating...
Vitaccess and Myasthenia Gravis Foundation of America form strategic partnership to advance generation of real-world evidence in MG
Boston, MA, USA and Oxford, UK – 12 February 2026. Vitaccess, a leader in generating science-driven real-world evidence, has entered into an exclusive partnership with the Myasthenia Gravis Foundation of America (MGFA), making the MGFA the official collaborator for...
Envision Pharma Group and Vitaccess create a global partnership
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry Move combines Envision’s global leadership position in medical affairs communications with Vitaccess’ award-winning capabilities in...
Vitaccess rebrand celebrates 4 years of ‘real progress’
Award-winning digital health leader, Vitaccess, is looking to the future with a bold, high-res rebrand. The striking new visual identity reflects Vitaccess’ meteoric rise as a global next-generation real-world evidence and strategy specialist. Vitaccess, founded by Dr...
